One of the thorniest dilemmas posed by prostate cancer is whether, and when, to give radiation therapy—with its potential bad side effects—to men after surgery to remove the prostate gland. Now, three new randomized clinical
COVID-19 has touched almost every country around the world since it emerged months ago. As of September 9, 2020, 27.6 million people have been infected with the SARS-CoV-2 virus, and there have been 898,000 deaths.
The first human trial of an antibody therapy to treat COVID-19 is underway, CNN reported Monday. According to drug maker Eli Lilly, the phase 1 trial is designed to find if the drug is safe
An initial trial in patients indicates that a new genetic treatment for complete color blindness, developed by research groups based in Tübingen and Munich is safe. Preliminary evidence for its efficacy has also been obtained.
Mice born blind have shown significant improvement in vision after undergoing a new gene therapy developed by a team of Japanese scientists. The results were published on January 24th in Nature Communications. This new method
Commercially available antivenoms in India can be ineffective in treating bites from certain medically important neglected snakes, a new study has shown. These snakes are those whose bites are harmful to humans, yet are poorly
As summer wanes and fall’s crisper winds usher us toward winter each year, seasonal affective Disorder (SAD) kicks in for millions of people. This type of depression typically recurs annually during the colder, darker months,
Mount Sinai researchers have identified a targeted therapy for adolescent patients with neuroblastoma, a deadly pediatric nerve cancer, who would otherwise have no treatment options, according to a study published in October in Cancer Cell.
A gene therapy being developed at Penn Medicine to treat Duchenne muscular dystrophy (DMD) successfully and safely stopped the severe muscle deterioration associated with the rare, genetic disease in both small and large animal models,
(HealthDay)—Patients with chronic coronary artery disease or peripheral artery disease treated with the combination of rivaroxaban and aspirin face a greater risk for bleeding versus patients treated with aspirin alone, according to a study published